Kwality Pharmaceuticals (NSE:KPL) Beta: N/A (As of Aug. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:KPL Kwality Pharmaceuticals Ltd NSE:KPL
60 GF Score
Price ₹3,630.30
GF Value ₹1,332.01
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Kwality Pharmaceuticals Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-08-21), Kwality Pharmaceuticals's Beta is Not available.

Kwality Pharmaceuticals  (NSE:KPL) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)

Kwality Pharmaceuticals Beta Related Terms

Kwality Pharmaceuticals Beta Historical Data

* Premium members only.

The historical data trend for Kwality Pharmaceuticals's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kwality Pharmaceuticals Beta Chart

Kwality Pharmaceuticals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Kwality Pharmaceuticals Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NSE:KPL
60GF Score
Kwality Pharmaceuticals Ltd NSE:KPL
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kwality Pharmaceuticals Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Is Kwality Pharmaceuticals (NSE:KPL) Overvalued in 2026?

Based on GuruFocus' analysis, Kwality Pharmaceuticals stock appears to be overvalued. The current stock price of ₹3,630.30 is trading 172.5% above its estimated GF Value™ of ₹1,332.01. GuruFocus considers Kwality Pharmaceuticals to be Significantly Overvalued.

Key valuation signals for NSE:KPL:

  • Beta: N/A
  • GF Value™: ₹1,332.01 vs. price of ₹3,630.30 (172.5% above fair value)
  • GF Score™: 60/100 with 6 warning signs

No single metric tells the full story. See the NSE:KPL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Kwality Pharmaceuticals Business Description

Comparable Companies
Other Exchanges 539997:India
Address Majitha Road, Village Nagkalan, 6th Mile Stone, Amritsar, PB, IND, 143601
Kwality Pharmaceuticals Ltd is an India-based pharmaceutical company. It is principally engaged in manufacturing finished pharmaceutical formulations in a dosage form. The company manufactures and exports pharmaceutical formulations in liquid orals, dry syrups, tablets, capsules, sterile powder for injections, and small-volume injectables.
60GF Score

Get the complete analysis for NSE:KPL

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹3,630.30
Price
₹1,332.01
GF Value